195 related articles for article (PubMed ID: 1676630)
1. Plasma pharmacokinetics and metabolism of 13-cis- and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis- and all-trans-retinoyl-beta-glucuronides. A comparison to one human case study with isotretinoin.
Kraft JC; Slikker W; Bailey JR; Roberts LG; Fischer B; Wittfoht W; Nau H
Drug Metab Dispos; 1991; 19(2):317-24. PubMed ID: 1676630
[TBL] [Abstract][Full Text] [Related]
2. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
[TBL] [Abstract][Full Text] [Related]
3. Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey.
Hummler H; Hendrickx AG; Nau H
Teratology; 1994 Sep; 50(3):184-93. PubMed ID: 7871482
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of oral 9-cis-retinoic acid in the human. Identification of 9-cis-retinoyl-beta-glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolites.
Sass JO; Masgrau E; Saurat JH; Nau H
Drug Metab Dispos; 1995 Sep; 23(9):887-91. PubMed ID: 8565776
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 13-cis-, all-trans-, 13-cis-4-oxo-, and all-trans-4-oxo retinoic acid after intravenous administration in the cynomolgus monkey.
Sandberg JA; Eckhoff C; Nau H; Slikker W
Drug Metab Dispos; 1994; 22(1):154-60. PubMed ID: 8149876
[TBL] [Abstract][Full Text] [Related]
6. Embryonic delivered dose of isotretinoin (13-cis-retinoic acid) and its metabolites in hamsters.
Eckhoff C; Willhite CC
Toxicol Appl Pharmacol; 1997 Sep; 146(1):79-87. PubMed ID: 9299599
[TBL] [Abstract][Full Text] [Related]
7. Identification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.
Tzimas G; Sass JO; Wittfoht W; Elmazar MM; Ehlers K; Nau H
Drug Metab Dispos; 1994; 22(6):928-36. PubMed ID: 7895612
[TBL] [Abstract][Full Text] [Related]
8. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
Eckhoff C; Chari S; Kromka M; Staudner H; Juhasz L; Rudiger H; Agnish N
Toxicol Appl Pharmacol; 1994 Mar; 125(1):34-41. PubMed ID: 8128493
[TBL] [Abstract][Full Text] [Related]
9. All-trans-retinoyl-beta-glucuronide is a potent teratogen in the mouse because of extensive metabolism to all-trans-retinoic acid.
Nau H; Elmazar MM; Rühl R; Thiel R; Sass JO
Teratology; 1996 Sep; 54(3):150-6. PubMed ID: 8987158
[TBL] [Abstract][Full Text] [Related]
10. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.
Tzimas G; Bürgin H; Collins MD; Hummler H; Nau H
Arch Toxicol; 1994; 68(2):119-28. PubMed ID: 8179481
[TBL] [Abstract][Full Text] [Related]
11. Microinjections of cultured rat conceptuses: studies with 4-oxo-all-trans-retinoic acid, 4-oxo-13-cis-retinoic acid and all-trans-retinoyl-beta-glucuronide.
Kraft JC; Bechter R; Lee QP; Juchau MR
Teratology; 1992 Mar; 45(3):259-70. PubMed ID: 1631780
[TBL] [Abstract][Full Text] [Related]
12. Xenopus laevis: a model system for the study of embryonic retinoid metabolism. III. Isomerization and metabolism of all-trans-retinoic acid and 9-cis-retinoic acid and their dysmorphogenic effects in embryos during neurulation.
Kraft JC; Juchau MR
Drug Metab Dispos; 1995 Oct; 23(10):1058-71. PubMed ID: 8654193
[TBL] [Abstract][Full Text] [Related]
13. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
Tzimas G; Thiel R; Chahoud I; Nau H
Toxicol Appl Pharmacol; 1997 Apr; 143(2):436-44. PubMed ID: 9144460
[TBL] [Abstract][Full Text] [Related]
14. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
Nau H
J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 13-cis-retinoic acid by a rat liver 9000g supernatant preparation.
Vane FM; Buggé CJ; Williams TH
Drug Metab Dispos; 1982; 10(3):212-9. PubMed ID: 6125352
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
Muindi JR; Frankel SR; Huselton C; DeGrazia F; Garland WA; Young CW; Warrell RP
Cancer Res; 1992 Apr; 52(8):2138-42. PubMed ID: 1559217
[TBL] [Abstract][Full Text] [Related]
17. Placental transfer and developmental effects of 9-cis retinoic acid in mice.
Kochhar DM; Jiang H; Penner JD; Heyman RA
Teratology; 1995 Apr; 51(4):257-65. PubMed ID: 7570368
[TBL] [Abstract][Full Text] [Related]
18. Comparative teratogenicity and metabolism of all-trans retinoic acid, all-trans retinoyl beta-glucose, and all-trans retinoyl beta-glucuronide in pregnant Sprague-Dawley rats.
Gunning DB; Barua AB; Olson JA
Teratology; 1993 Jan; 47(1):29-36. PubMed ID: 8475455
[TBL] [Abstract][Full Text] [Related]
19. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice.
Achkar CC; Bentel JM; Boylan JF; Scher HI; Gudas LJ; Miller WH
Drug Metab Dispos; 1994; 22(3):451-8. PubMed ID: 8070324
[TBL] [Abstract][Full Text] [Related]
20. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
Shirley MA; Bennani YL; Boehm MF; Breau AP; Pathirana C; Ulm EH
Drug Metab Dispos; 1996 Mar; 24(3):293-302. PubMed ID: 8820419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
